Equine encephalosis virus (EEV) is the cause of equine encephalosis. The disease is similar to mild forms of African horse sickness (AHS) and the two diseases are easily confused. Laboratory identification and serotyping of EEV is based on viral isolation in BHK-21 cells and a viral plaque inhibition neutralization test. These procedures are time-consuming and therefore a more rapid diagnostic assay for EEV that can distinguish EEV from African horse sickness virus (AHSV) infections was developed.
There are seven serotypes of EEV. These are EEV-1 (Bryanston), EEV-2 (Cascara), EEV-3 (Gamil), EEV-4 (Kaalplaas), EEV-5 (Kyalami), EEV-6 (Potchefstroom), and EEV-7 (E21/20) (Gorman et al., 1983; Howell et al., 2002) .
Most EEV infections are subclinical in nature and mild forms are confused easily with mild forms of African horse sickness virus (AHSV) infections, as both infections exhibit similar clinical signs (Howell et al., 2004) . This makes diagnosis difficult and laboratory tests are needed to differentiate the diseases. There are various laboratory methods used in the diagnosis of EEV infection. Isolation of the virus is performed in baby hamster kidney (BHK) cells, suckling mice brains, or embryonated hen's eggs (Erasmus et al., 1970) . The virus is serotyped by the plaque inhibition neutralization assay (Quan et al., 2008) . A serological group-specific, indirect sandwich enzyme-linked immunosorbent assay (ELISA) is available for the detection of EEV antigen (Crafford et al., 2003) . Tests for antibody detection include complement fixation (CF), agar gel immunodiffusion (AGID) or indirect immunofluorescent antibody (IFA) tests (Howell et al., 2004) . The disadvantages of these methods are that they are time-consuming and only provide a retrospective diagnosis.
To date, no reverse transcription polymerase chain reaction (RT-PCR)-based assay for the detection of EEV nucleic acid has been described. Real-time RT-PCR provides several advantages over the use of conventional PCR and ELISA, including rapid turn-around with high analytical specificity, sensitivity and a reduced risk for contamination. As the clinical signs of AHSV and EEV infections in equines may be difficult to distinguish a rapid and reliable diagnostic real-time RT-PCR assay for EEV is needed to for rapid diagnosis of this infection. This paper describes the development and optimisation of a real-time RT-PCR assay for the sensitive and specific detection of EEV in samples from horses infected naturally with EEV. This was accomplished by sequencing the S7 (VP7) gene of 38 EEV isolates representing all seven serotypes and identifying a conserved region for the design of an EEV real-time RT-PCR assay using a TaqMan® MGB™ hydrolysis probe. Critical control parameters of the assay, as well as the repeatability, analytical sensitivity and specificity of the assay were estimated.
Materials and methods

Development of EEV real-time RT-PCR assay
An EEV S7 (VP7) gene sequence (FJ183391) obtained from GenBank® (www.ncbi.nlm.nih.gov/genbank) was used with FastPCR software V6.1.47 (Kalendar et al., 2009 ) to design terminal primers for amplification and sequencing of the EEV S7 gene.
EEV isolates representing all seven recognized serotypes of EEV were sequences (Table 1) .
Viral dsRNA was extracted from EEV cell culture isolates. The contents of a flask were agitated and 500 μl transferred to a 1.5 ml eppendorf tube. Samples were spun at 11 000 g for 5 min in a 5417C centrifuge (Eppendorf). The supernatant was discarded and the cell pellet mixed with 50 μl of phosphate buffered saline (PBS). Total nucleic acid extractions from the cell pellet were performed using a MagMax™-96 Total RNA Isolation kit (Lifetech), according to the manufacturer's instructions. The samples were processed in a MagMax™ Express Particle Processor (Lifetech) and a custom Extracted viral nucleic acid was denatured with 0.2 M of methyl mercury (II) hydroxide (MMOH) and amplified with a one-step RT-PCR as described previously (Quan et al., 2008) . The EEV S7 gene was amplified in two overlapping sections using primer EEV_VP7_F0007_0027 (ttt ggc caa caa gat gga tgc) with primer EEV_VP7_R0588_0609 (ctc gtg tac att gca aaa ggt c), and primer EEV_VP7_F0495_0516 (ttc agg tga gcc tta cgc cga a) with primer EEV_VP7_R1151_1175 (gta aca cgt ttg gcc tca gac gtt t). An annealing temperature of 55 °C was used and the PCR products visualized on a 1.5 % agarose gel prepared with TAE buffer.
ExoSAP-IT (Affymetrix) was used according to the manufacturer's instructions to purify the PCR products. Sequencing reactions were prepared using a BigDye Terminator v3.1 cycle sequencing kit (Lifetech). Reactions consisted of 2 μl Ready Reaction Premix, 1 μl of BigDye Sequencing Buffer, 3.2 pmol primer and 5 μl PCR products made up to 10 μl in H2O. A standard sequencing protocol and sequencing product purification method using ethanol/NaOAc/EDTA precipitation (Lifetech) was followed. Samples were analysed with an ABI 3130xl Genetic Analyzer (Lifetech) using POP-7 polymer and a 36 cm capillary.
The Staden software package v1.5 (Staden, 1996; Staden et al., 2000) was used for sequence assembly, ClustalX v2.0.5 (Larkin et al., 2007) to align sequences and BioEdit Sequence Alignment Editor v7.0.9 software (Hall, 1999) to edit sequences. Conserved regions within the S7 gene were identified and used to design a real-time RT-PCR assay with a TaqMan® minor groove binder (MGB™) hydrolysis probe, using Primer Express 3.0 software (Lifetech) and FastPCR software v6.1.47 (Kalendar et al., 2009 ).
EEV real-time RT-PCR assay
The nucleic acid from 50 µl of blood was extracted using a MagMax™-96 Total RNA Isolation kit (Lifetech) according to the manufacturer's instructions, and a MagMax™ Express Particle Processor (Lifetech). Nucleic acid was eluted in 50 μl Elution Buffer.
Five μl RNA were added to 1 μl 25X primer/probe mixture (400 nM/120 nM final concentrations) and 4 μl nuclease-free water. The probe was labeled with NED™ (Lifetech). The mixture was denatured by heating at 95 °C for 1 min on a heatblock, and then cooled quickly on ice. VetMAX™-Plus One-
Step RT-PCR kit (Lifetech) reagents were added (12.5 μl 2X RT-PCR buffer, 1.5 μl nuclease free water and 1 μl enzyme). The assay was performed following the manufacturer's recommendations on a StepOnePlus™ Real-Time PCR System (Lifetech). Samples were classified as positive if the normalised fluorescence for the EEV assay exceeded a 0.1 threshold.
Assay characteristics
The assay was tested on tissue culture reference isolates of 24 serotypes of BTV, nine serotypes of AHSV and seven serotypes of EEV to determine the analytical specificity.
The efficiency of the assay was calculated using a ten-fold dilution series of blood (negative for EEV by virus isolation and RT-PCR and obtained from a clinically normal horse) spiked with EEV-2 obtained from tissue culture isolation (E118/12, 10 7.9 TCID 50 /ml). The dilution series was tested five times in a single run. PCR efficiency were determined by the formula: PCR efficiency (%) = 100 × (10 1/slope −1).
A two-fold dilution series, consisting of six separate dilutions of EEV-spiked blood, was made to cover the non-linear range of the assay. Each dilution was extracted five times and each extract tested in five independent runs. The results of these analyses were used to calculate the 95 % limit of detection (LOD) (input concentration giving a positive result in 95 % of the replicates) by probit analysis.
The inter-run, intra-run and total standard deviations (SD) were calculated by the formulas: inter-run SD, standard deviation of the means of all runs; intra-run SD, mean of the standard deviations of all runs; total SD, standard deviation of all replicates. The total coefficient of variation (CV) was calculated by the formula: total CV = total SD/(mean cycle threshold (C T )-value of all replicates).
Results
Primer design
The EEV S7 genes of isolates all 7 serotypes of EEV was amplified in two overlapping segments 581 bp and 656 bp in length ( Table 1 ).
The minimum percentage identity between isolates was 92.6 % (82 differences out of 1123 nucleotides). These differences occurred between the reference EEV-6 (Potchefstroom) strain, and EEV-5/EEV-7 isolates.
Conserved regions within the EEV S7 gene were identified ( Figure 1a ) and a 78 nucleotide TaqMan® MGB™ real-time RT-PCR developed at the 5'-end of the S7 gene (Figure 1b Table 2 and supplementary data). There was 100 % identity of the forward primer and TaqMan® MGB™ hydrolysis probe with all the EEV S7 sequences. A redundant reverse primer was designed as there was one nucleotide mismatch between the primer and the EEV S7 sequences. A BLAST analysis of the primers and probe showed specificity for EEV sequences.
An alignment of EEV, epizootic hemmorhagic disease virus (EHDV), BTV and AHSV S7 sequences showed very little identity between the viruses. Using FJ183391 as a reference, there was maximum identity of 72 % over a 16 % region of the EHDV S7 gene, 66% over a 18 % region of the BTV S7 gene, and 66% over a 28% region of the AHSV S7gene.
Assay characteristics
The EEV real-time RT-PCR assay was specific, detecting all seven serotypes of EEV, but not AHSV nor BTV (Table 3 ).
The assay was linear in the range tested, i.e. 10 2.9 -10 6.9 TCID 50 /ml blood. The efficiency of the assay was calculated to be 81 % (Figure 2a ).
The assay was sensitive, with a 95 % LOD determined by probit analysis of 10 2.9 TCID 50 /ml blood (95 % confidence interval: 10 2.7 -10 3.3 ) (Figure 2b ). This corresponded a C T of 38.42. Cycle threshold (C T )
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Log TCID 50 Both intra-and inter-run standard deviations (SD) were low with maxima at 0.47 C T and 2.07 C T , respectively (Table 4 ). The coefficient of variation (CV) ranged from 1.1 % to 5.6 %, indicating low variation between different repetitions and different runs.
Discussion
Equine encephalosis is a generally a mild or subclinical disease of horses. Although EEV is occasionally isolated from organs of dead horses it is not a World Organisation for Animal Health (OIE) listed disease. It does, however, play a very important role as a differential diagnosis for mild cases of AHS, a high impact disease listed by the OIE. Both diseases can present with similar clinical signs, are caused by (Orbiviruses) and are seasonal, with a peak incidence at the end of summer, when Culicoides midge numbers are at their highest. It is imperative to distinguish between AHS and equine encephalosis, as the control measures and consequences differ vastly. In South Africa, AHS is a controlled notifiable disease, whilst equine encephalosis is not.
The S7 gene of EEV is translated into the VP7 protein, which makes up the outer layer of the inner capsid of the EEV. The inner capsid is covered by the outer capsid, a layer of proteins composed of VP2 and VP5. VP7 has limited exposure on the surface of the intact virion, but is a highly immunedominant antigen and antibodies against VP7 can be detected by an ELISA (Crafford et al., 2003) .
The aim of this study was to develop a specific, sensitive, rapid and robust real-time RT-PCR assay for the detection of EEV and the S7 gene was selected as a target as it is highly conserved among serotypes and serogroups (Bremer et al., 1990; Mertens et al., 1984) . As only two epitopes of the S7 gene are expressed on the surface of the virus (Anthony et al., 2007) , the mutation rate of the gene due to immune pressure may be quite low.
The sequences of 38 EEV isolates, including all seven serotypes of EEV, as well as all the reference strains of EEV were obtained. The S7 gene was relatively well conserved with 92.6 -100 % identity between the 38 isolates sequenced. The terminal ends of the S7 gene were more conserved than the middle region, similar to AHSV VP7 and NS2 sequences (Quan et al., 2010) . The conserved region at the 5' end of the S7 gene (115 nucleotides) was longer than the 3' end, so the real-time RT-PCR assay was designed to target the former region.
The TaqMan® MGB™ RT-PCR assay developed for detection of EEV nucleic acid is specific and quick to perform, as it does not require visualization of the PCR products by electrophoresis. The elimination of this step saves laboratory equipment and reagents, but require a more advanced and expensive real-time thermocycler which is not available in every diagnostic laboratory. The real-time reagents are much more expensive than those used in conventional PCR, but the assay provides a convenient way of obtaining reproducible results within a short time.
The assay can be used to detect rapidly and reliably any of the EEV strains that were tested in cell or tissue culture and to distinguish EEV from AHSV. It will be useful in endemic countries where both viruses are circulating to ensure that correct control strategies are used.
As the assay was planned to be used in a multiplex format, the testing was done with a probe labeled with NED™ dye. On the StepOnePlus Real-Time PCR™ system, the efficiency of the assay appears to vary with the dye that is used. The efficiency of the same assay with 6-FAM or VIC® appears to be much higher than with the NED™ dye (personal observation). This may explain why the efficiency of the assay was not higher and closer to 100 %.
The 95 % LOD of the assay was 10 2.9 TCID 50 /ml blood. There are no other published real-time RT-PCR EEV assays to compare with, but assays for AHSV have reported an end-point LOD of 10 1.5 (Agüero at el., 2008), 10-0.90 (Fernández-Pinero et al., 2008) and 10 -0.08 (Rodriguez-Sanchez et al., 2008) TCID 50 /ml. As these are end-point LODs, the assay appears to compare favourably. Monaco et al., (2011) reported a 95 % LOD of 10 0.33 TCID 50 /ml for an AHSV assay, which is more sensitive than the EEV assay. It is possible that the sensitivity of the EEV could be increased with the use of different dyes, e.g. FAM or VIC® on the probes.
The results described in this study contribute to the improvement of the available techniques for the detection of EEV antigen and/or antibodies against EEV. So far, the only group-specific EEV assay is the indirect sandwich ELISA for the detection of EEV antigen (Crafford et al., 2003) . The assay takes a day to obtain results. To date, there is no publishedmolecular assay for EEV and this is the first study to describe a real-time RT-PCR assay for the detection of EEV. 
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